Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases. Le Tilly O, Paintaud G, Ternant D. JAMA 2021;326:1069.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Le Tilly O, Paintaud G, Ternant D. Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases. JAMA 2021;326:1069.
PMID: 34546307